Topical preparations for skin hyperpigmentation
- 24 April 2023
- journal article
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 22 (5)
Abstract
Hyperpigmentation is a very common group of conditions with a pronounced negative impact on patients’ quality of life, that requires the necessity of development and search of effective and safe means to control it. Today, the market of depigmentary cosmetics is extremely various, and its global financial turnover continues to grow, that confirms the relevance of whitening products. The article presents the classification and review of modern preparations for hyperpigmentation treatment. The used drugs are divided into different classes depending on the mechanism of action. Conducted studies have shown that inhibitors of tyrosinase, a key enzyme in melanin synthesis, are the most effective group. Till recently, tyrosinase produced by mushrooms due to its commercial availability has been used for the synthesis and study of tyrosinase inhibitors in factories, so many of the released whitening agents are not clinically effective for control of hyperpigmentation in humans. It has been established that isobutylamido-thiazolyl-resorcinol has the most specific action for human’s tyrosinase. The molecule has a higher efficacy and better safety profile than other substances of the group, such as arbutin and hydroquinone, which were once the golden standard for skin hyperpigmentation treatment.Keywords
This publication has 68 references indexed in Scilit:
- The mechanism of action and clinical benefits of soy for the treatment of hyperpigmentationInternational Journal of Dermatology, 2011
- Mechanisms Regulating Skin Pigmentation: The Rise and Fall of Complexion ColorationInternational Journal of Molecular Sciences, 2009
- An Updated Review of Tyrosinase InhibitorsInternational Journal of Molecular Sciences, 2009
- Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activityJournal of Cosmetic Dermatology, 2008
- LIGR, a protease‐activated receptor‐2‐derived peptide, enhances skin pigmentation without inducing inflammatory processesPigment Cell & Melanoma Research, 2008
- The treatment of melasma: A review of clinical trialsJournal of the American Academy of Dermatology, 2006
- Postinflammatory hyperpigmentation: a common but troubling conditionInternational Journal of Dermatology, 2004
- All-trans Retinoic Acid Induces Differentiation and Apoptosis of Murine Melanocyte Precursors with Induction of the Microphthalmia-Associated Transcription FactorJournal of Investigative Dermatology, 2002
- The Effects of Topical L(+) Lactic Acid and Ascorbic Acid on Skin WhiteningInternational Journal of Cosmetic Science, 1999
- Differential Regulation of Tyrosinase Activity in Skin of White and Black Individuals In Vivo by Topical Retinoic AcidJournal of Investigative Dermatology, 1993